Klaus Lieb
#136,455
Most Influential Person Now
German psychiatrist
Klaus Lieb's AcademicInfluence.com Rankings
Download Badge
Biology
Why Is Klaus Lieb Influential?
(Suggest an Edit or Addition)Klaus Lieb's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Psychological therapies for people with borderline personality disorder. (2012) (602)
- Effectiveness of inpatient dialectical behavioral therapy for borderline personality disorder: a controlled trial. (2004) (481)
- Pharmacotherapy for borderline personality disorder: Cochrane systematic review of randomised trials (2010) (354)
- Frontolimbic brain abnormalities in patients with borderline personality disorder a volumetric magnetic resonance imaging study (2003) (347)
- The resilience framework as a strategy to combat stress-related disorders (2017) (328)
- Intervention studies to foster resilience - A systematic review and proposal for a resilience framework in future intervention studies. (2018) (317)
- Shame and implicit self-concept in women with borderline personality disorder. (2007) (287)
- Neural correlates of antinociception in borderline personality disorder. (2006) (265)
- Pain perception during self-reported distress and calmness in patients with borderline personality disorder and self-mutilating behavior (2000) (249)
- Expression and regulation of cyclooxygenase-2 in rat microglia. (1997) (248)
- Non-medical use of prescription stimulants and illicit use of stimulants for cognitive enhancement in pupils and students in Germany. (2011) (240)
- Pharmacological interventions for borderline personality disorder. (2010) (237)
- State affective instability in borderline personality disorder assessed by ambulatory monitoring (2007) (225)
- Behavioral components of impulsivity. (2014) (224)
- Cyclooxygenase‐2 expression in rat microglia is induced by adenosine A2a‐receptors (1996) (214)
- The neuropeptide substance P activates transcription factor NF-kappa B and kappa B-dependent gene expression in human astrocytoma cells. (1997) (190)
- Attention-deficit hyperactivity disorder as a potentially aggravating factor in borderline personality disorder (2008) (185)
- Affective dysregulation and dissociative experience in female patients with borderline personality disorder: a startle response study. (2005) (179)
- Self-stigma, empowerment, and perceived legitimacy of discrimination among women with mental illness. (2006) (178)
- A voxel-based morphometric MRI study in female patients with borderline personality disorder (2003) (171)
- Borderline personality disorder (2004) (170)
- Randomized Response Estimates for the 12‐Month Prevalence of Cognitive‐Enhancing Drug Use in University Students (2013) (168)
- Interferon alpha (IFNα) and psychiatric syndromes A review (2002) (165)
- Self-Stigma in Women With Borderline Personality Disorder and Women With Social Phobia (2006) (160)
- Increased nocturnal interleukin-6 excretion in patients with primary insomnia: A pilot study (2006) (160)
- Differential nociceptive deficits in patients with borderline personality disorder and self-injurious behavior: laser-evoked potentials, spatial discrimination of noxious stimuli, and pain ratings (2004) (155)
- Disentangling common and specific neural subprocesses of response inhibition (2013) (153)
- Psychological interventions for antisocial personality disorder. (2010) (149)
- Methylation of the promoter of brain-derived neurotrophic factor exon IV and antidepressant response in major depression (2014) (148)
- Use of illicit and prescription drugs for cognitive or mood enhancement among surgeons (2013) (147)
- Pharmacological interventions for antisocial personality disorder. (2010) (145)
- A meta‐analysis of executive dysfunctions in unipolar major depressive disorder without psychotic symptoms and their changes during antidepressant treatment (2012) (141)
- A coordinate-based ALE functional MRI meta-analysis of brain activation during verbal fluency tasks in healthy control subjects (2014) (141)
- Elevated pain thresholds correlate with dissociation and aversive arousal in patients with borderline personality disorder (2007) (141)
- Prefrontal cortical hypometabolism during low-dose interferon alpha treatment (2000) (140)
- The Neuropeptide Substance P Activates p38 Mitogen-Activated Protein Kinase Resulting in IL-6 Expression Independently from NF-κB1 (2000) (138)
- An intensive treatment program of interpersonal psychotherapy plus pharmacotherapy for depressed inpatients: acute and long-term results. (2007) (137)
- SPM-based count normalization provides excellent discrimination of mild Alzheimer's disease and amnestic mild cognitive impairment from healthy aging (2009) (131)
- Signal transduction pathways regulating cyclooxygenase‐2 in lipopolysaccharide‐activated primary rat microglia (2005) (130)
- World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Personality Disorders (2007) (130)
- Genome-wide association study of borderline personality disorder reveals genetic overlap with bipolar disorder, major depression and schizophrenia (2017) (129)
- Measuring shame and guilt by self-report questionnaires: A validation study (2007) (128)
- Frontal Dysfunctions of Impulse Control – A Systematic Review in Borderline Personality Disorder and Attention-Deficit/Hyperactivity Disorder (2014) (125)
- Psychological interventions for resilience enhancement in adults (2017) (120)
- Contact between Doctors and the Pharmaceutical Industry, Their Perceptions, and the Effects on Prescribing Habits (2014) (118)
- Ambient Air Pollution Increases the Risk of Cerebrovascular and Neuropsychiatric Disorders through Induction of Inflammation and Oxidative Stress (2020) (117)
- Psycho-social factors associated with mental resilience in the Corona lockdown (2020) (116)
- Impulsivity in Borderline Personality Disorder: A Matter of Disturbed Impulse Control or a Facet of Emotional Dysregulation? (2013) (115)
- Substance P Receptor Antagonists in Psychiatry (2005) (114)
- Population-based validation of a German version of the Brief Resilience Scale (2018) (114)
- Psychological therapies for people with borderline personality disorder. (2012) (113)
- Impulsivity in Borderline Personality Disorder: Impairment in Self-Report Measures, but Not Behavioral Inhibition (2010) (112)
- Reliability of three alternate forms of the trail making tests a and B. (2011) (106)
- Mental burden and its risk and protective factors during the early phase of the SARS-CoV-2 pandemic: systematic review and meta-analyses (2021) (106)
- Neurokinin-1 Receptor Expression and Its Potential Effects on Tumor Growth in Human Pancreatic Cancer (2003) (105)
- Predictors of dropout from inpatient dialectical behavior therapy among women with borderline personality disorder. (2008) (104)
- Prostaglandin E2 Induces Interleukin‐6 Synthesis in Human Astrocytoma Cells (1997) (103)
- Inferior frontal white matter microstructure and patterns of psychopathology in women with borderline personality disorder and comorbid attention-deficit hyperactivity disorder (2007) (101)
- Psychological interventions to foster resilience in healthcare professionals. (2020) (101)
- Increased diurnal salivary cortisol in women with borderline personality disorder. (2004) (100)
- Inhibition of LPS-induced p42/44 MAP kinase activation and iNOS/NO synthesis by parthenolide in rat primary microglial cells (2002) (99)
- Interferon alpha (IFNalpha) and psychiatric syndromes: a review. (2002) (98)
- Substances used and prevalence rates of pharmacological cognitive enhancement among healthy subjects (2014) (97)
- The financing of drug trials by pharmaceutical companies and its consequences. Part 1: a qualitative, systematic review of the literature on possible influences on the findings, protocols, and quality of drug trials. (2010) (95)
- Sleep in adults with attention-deficit/hyperactivity disorder: a controlled polysomnographic study including spectral analysis of the sleep EEG. (2005) (95)
- What Users Think about the Differences between Caffeine and Illicit/Prescription Stimulants for Cognitive Enhancement (2012) (88)
- Increased CSF APPs-α levels in patients with Alzheimer disease treated with acitretin (2014) (88)
- Subtle prefrontal neuropathology in a pilot magnetic resonance spectroscopy study in patients with borderline personality disorder. (2001) (87)
- Pharmacotherapy for Borderline Personality Disorder—Current Evidence and Recent Trends (2014) (87)
- Effects of caffeine and paracetamol alone or in combination with acetylsalicylic acid on prostaglandin E2 synthesis in rat microglial cells (2000) (85)
- Positron emission tomography in female patients with borderline personality disorder. (2003) (85)
- Gender Differences in Axis I and Axis II Comorbidity in Patients with Borderline Personality Disorder (2009) (85)
- Inhibition of LPS-induced iNOS and NO synthesis in primary rat microglial cells (2003) (81)
- Pathways of inflammatory activation in Alzheimer's disease: potential targets for disease modifying drugs. (2002) (81)
- A survey of german physicians in private practice about contacts with pharmaceutical sales representatives. (2010) (80)
- Clonidine in acute aversive inner tension and self-injurious behavior in female patients with borderline personality disorder. (2004) (80)
- The 5-HT3 receptor antagonist tropisetron inhibits T cell activation by targeting the calcineurin pathway. (2005) (79)
- Regulation of prostaglandin E2 synthase expression in activated primary rat microglia: Evidence for uncoupled regulation of mPGES‐1 and COX‐2 (2008) (78)
- Cognitive impairment in patients with chronic hepatitis treated with interferon alpha (IFNα): results from a prospective study (2006) (76)
- Medial prefrontal dysfunction and prolonged amygdala response during instructed fear processing in borderline personality disorder (2013) (75)
- Borderline personality disorder and comorbid addiction: epidemiology and treatment. (2014) (75)
- Association between psychological resilience and changes in mental distress during the COVID-19 pandemic (2020) (74)
- The financing of drug trials by pharmaceutical companies and its consequences: part 2: a qualitative, systematic review of the literature on possible influences on authorship, access to trial data, and trial registration and publication. (2010) (74)
- The early non-increase of serum BDNF predicts failure of antidepressant treatment in patients with major depression: A pilot study (2011) (73)
- Deep brain stimulation for treatment of refractory depression (2005) (73)
- Emotional modulation of motor response inhibition in women with borderline personality disorder: an fMRI study. (2013) (72)
- Neurotransmitter changes by interferon-alpha and therapeutic implications. (2003) (71)
- Interleukin-6-associated inflammatory processes in Alzheimer's disease: New therapeutic options (1996) (69)
- Neural correlates of interference inhibition, action withholding and action cancelation in adult ADHD (2012) (68)
- Dissociable attentional and inhibitory networks of dorsal and ventral areas of the right inferior frontal cortex: a combined task-specific and coordinate-based meta-analytic fMRI study (2016) (68)
- Emotional Reactions to Standardized Stimuli in Women With Borderline Personality Disorder: Stronger Negative Affect, But No Differences in Reactivity (2009) (67)
- Serotonin via 5‐HT7 receptors activates p38 mitogen‐activated protein kinase and protein kinase C ɛ resulting in interleukin‐6 synthesis in human U373 MG astrocytoma cells (2005) (66)
- Effects of the Neuropeptide Substance P on Sleep, Mood, and Neuroendocrine Measures in Healthy Young Men (2002) (66)
- Escitalopram for the Prevention of Peginterferon-α2a–Associated Depression in Hepatitis C Virus–Infected Patients Without Previous Psychiatric Disease (2012) (66)
- Dissecting the Shared Genetic Architecture of Suicide Attempt, Psychiatric Disorders, and Known Risk Factors (2020) (66)
- The 5-HTTLPR polymorphism modulates the association of serious life events (SLE) and impulsivity in patients with Borderline Personality Disorder. (2009) (66)
- Interleukin‐1β Uses Common and Distinct Signaling Pathways for Induction of the Interleukin‐6 and Tumor Necrosis Factor α Genes in the Human Astrocytoma Cell Line U373 (1996) (65)
- Modulatory role of the brain‐derived neurotrophic factor Val66Met polymorphism on the effects of serious life events on impulsive aggression in borderline personality disorder (2010) (65)
- Time course of response to antidepressants: predictive value of early improvement and effect of additional psychotherapy. (2009) (65)
- Life context of pharmacological academic performance enhancement among university students – a qualitative approach (2014) (65)
- Early reactions of brain-derived neurotrophic factor in plasma (pBDNF) and outcome to acute antidepressant treatment in patients with Major Depression (2012) (64)
- Neurotoxicity of Dopamine and Protective Effects of the NMDA Receptor Antagonist AP-5 Differ between Male and Female Dopaminergic Neurons (1995) (63)
- Effects of substance P and selected other neuropeptides on the synthesis of interleukin-1 β and interleukin-6 in human monocytes: a re-examination (1996) (62)
- Substance P and Histamine Induce Interleukin‐6 Expression in Human Astrocytoma Cells by a Mechanism Involving Protein Kinase C and Nuclear Factor‐IL‐6 (1998) (61)
- Use of Coffee, Caffeinated Drinks and Caffeine Tablets for Cognitive Enhancement in Pupils and Students in Germany (2011) (61)
- Increased delta power and discrepancies in objective and subjective sleep measurements in borderline personality disorder. (2005) (61)
- Differential impact of COVID‐related lockdown on mental health in Germany (2021) (59)
- The catechol o‐methyltransferase (COMT) val158met polymorphism modulates the association of serious life events (SLE) and impulsive aggression in female patients with borderline personality disorder (BPD) (2010) (58)
- Time course of anger and other emotions in women with borderline personality disorder: a preliminary study. (2008) (57)
- Pre- and postnatal development of dopaminergic neuron numbers in the male and female mouse midbrain. (1996) (57)
- Extraction of prefronto-amygdalar pathways by combining probability maps (2009) (57)
- New developments in the neurobiology of borderline personality disorder (2004) (56)
- Associations between Physical and Cognitive Doping – A Cross-Sectional Study in 2.997 Triathletes (2013) (56)
- Interleukin‐1β and Tumor Necrosis Factor‐α Induce Expression of α1‐Antichymotrypsin in Human Astrocytoma Cells by Activation of Nuclear Factor‐κB (1996) (55)
- Small amygdala – high aggression? The role of the amygdala in modulating aggression in healthy subjects (2012) (55)
- [Pharmacological neuroenhancement and brain doping : Chances and risks]. (2010) (54)
- Evaluation of the efficacy and effectiveness of a structured disorder tailored psychotherapy in ADHD in adults: study protocol of a randomized controlled multicentre trial (2010) (54)
- Methylphenidate, modafinil, and caffeine for cognitive enhancement in chess: A double-blind, randomised controlled trial (2017) (54)
- Attitudes Toward Cognitive Enhancement in Users and Nonusers of Stimulants for Cognitive Enhancement: A Pilot Study (2012) (53)
- Borderline typical symptoms in adult patients with attention deficit/hyperactivity disorder (2009) (51)
- Psychomorbidity, Resilience, and Exacerbating and Protective Factors During the SARS-CoV-2 Pandemic. (2020) (51)
- Naloxone in the treatment of acute dissociative states in female patients with borderline personality disorder. (2004) (51)
- Reduced interhemispheric structural connectivity between anterior cingulate cortices in borderline personality disorder (2010) (50)
- Substance P and Substance P Receptor Antagonists in the Pathogenesis and Treatment of Affective Disorders (2003) (48)
- Corpus callosum abnormalities in women with borderline personality disorder and comorbid attention-deficit hyperactivity disorder. (2007) (48)
- Impact of COVID-19 lockdown on mental health in Germany: longitudinal observation of different mental health trajectories and protective factors (2021) (48)
- No Borna disease virus-specific RNA detected in blood from psychiatric patients in different regions of Germany (1997) (48)
- Differential Effects of Human and Pork Insulin–Induced Hypoglycemia on Neuronal Functions in Humans (1990) (48)
- Ascorbic acid enhances the inhibitory effect of aspirin on neuronal cyclooxygenase-2-mediated prostaglandin E2 production (2006) (47)
- Anti-inflammatory drugs: a hope for Alzheimer’s disease? (2000) (47)
- Early Life Stress Differentially Modulates Distinct Forms of Brain Plasticity in Young and Adult Mice (2012) (46)
- Responding to the Treatment Challenge of Patients with Severe BPD: Results of Three Pilot Studies of Inpatient Schema Therapy (2013) (45)
- Interaction between gene variants of the serotonin transporter promoter region (5‐HTTLPR) and catechol O‐methyltransferase (COMT) in borderline personality disorder (2009) (45)
- Early life stress stimulates hippocampal reelin gene expression in a sex‐specific manner: Evidence for corticosterone‐mediated action (2012) (45)
- Age‐related increases in stroop interference: Delineation of general slowing based on behavioral and white matter analyses (2014) (45)
- Subtype Differentiation of Patients with Borderline Personality Disorder Using a Circumplex Model of Interpersonal Behavior (2003) (44)
- Conflicts of interest and spin in reviews of psychological therapies: a systematic review (2016) (43)
- Evaluation of naltrexone for dissociative symptoms in borderline personality disorder (2012) (42)
- Impairment in preattentive visual processing in patients with Parkinson's disease. (1999) (41)
- Synergistic inhibitory effect of ascorbic acid and acetylsalicylic acid on prostaglandin E2 release in primary rat microglia (2003) (41)
- Borna disease virus in human brains with a rare form of hippocampal degeneration but not in brains of patients with common neuropsychiatric disorders. (1999) (41)
- Molecular cause and functional impact of altered synaptic lipid signaling due to a prg‐1 gene SNP (2015) (40)
- State dependent posterior hippocampal volume increases in patients with major depressive disorder. (2011) (40)
- Construct Validity and Population-Based Norms of the German Brief Resilience Scale (BRS) (2018) (40)
- No response of plasma substance P, but delayed increase of interleukin-1 receptor antagonist to acute psychosocial stress. (2006) (40)
- Evidence of disturbed amygdalar energy metabolism in patients with borderline personality disorder (2007) (39)
- Psychological interventions to foster resilience in healthcare students: a Cochrane Review (2020) (38)
- The Impact of Posttraumatic Stress Disorder on Dysfunctional Implicit and Explicit Emotions Among Women With Borderline Personality Disorder (2007) (38)
- The Use of Caffeinated Substances by Surgeons for Cognitive Enhancement. (2015) (37)
- Non-Pharmacologic Multicomponent Interventions Preventing Delirium in Hospitalized People. (2020) (36)
- Pharmacotherapy for Borderline Personality Disorder: an Update of Published, Unpublished and Ongoing Studies (2020) (36)
- Effects of sleep deprivation on nocturnal cytokine concentrations in depressed patients and healthy control subjects. (2012) (36)
- Serum levels of substance P and response to antidepressant pharmacotherapy. (2004) (35)
- Effects of Shame Induction in Borderline Personality Disorder (2013) (35)
- Pharmakologisches Neuroenhancement und „Hirndoping“ (2010) (35)
- Interventions to Promote Resilience in Cancer Patients. (2019) (34)
- Stimulation of the sphingomyelin pathway induces interleukin-6 gene expression in human astrocytoma cells (1995) (33)
- Preattentive information processing as measured by backward masking and texton detection tasks in adolescents at high genetic risk for schizophrenia (1996) (33)
- Randomized controlled study of early medication change for non-improvers to antidepressant therapy in major depression – The EMC trial (2016) (32)
- Effects of NSAIDs on IL‐1β‐induced IL‐6 mRNA and protein synthesis in human astrocytoma cells (1996) (32)
- Peripheral blood and neuropsychological markers for the onset of action of antidepressant drugs in patients with Major Depressive Disorder (2011) (31)
- Reflections on Addiction in Students Using Stimulants for Neuroenhancement: A Preliminary Interview Study (2015) (30)
- Women with borderline personality disorder do not show altered BOLD responses during response inhibition (2015) (30)
- Borna disease virus--does it infect humans and cause psychiatric disorders? (2001) (30)
- Mental health in refugees and asylum seekers (MEHIRA): study design and methodology of a prospective multicentre randomized controlled trail investigating the effects of a stepped and collaborative care model (2019) (30)
- Identification of disulfiram as a secretase-modulating compound with beneficial effects on Alzheimer’s disease hallmarks (2018) (30)
- Comparison of different strategies to decrease negative affect and increase positive affect in women with borderline personality disorder. (2011) (30)
- Neurochemical alterations in women with borderline personality disorder and comorbid attention-deficit hyperactivity disorder (2010) (30)
- Mental resilience in the Corona lockdown: First empirical insights from Europe (2020) (30)
- Decoding the Mechanism of Action of Rapid-Acting Antidepressant Treatment Strategies: Does Gender Matter? (2019) (30)
- Substance P and Affective Disorders: New Treatment Opportunities by Neurokinin 1 Receptor Antagonists? (2002) (29)
- Transient total sleep loss in cerebral Whipple's disease: a longitudinal study (2002) (29)
- Interventions to Ameliorate the Psychosocial Effects of the COVID-19 Pandemic on Children—A Systematic Review (2021) (29)
- Rationale and design of the randomised clinical trial comparing early medication change (EMC) strategy with treatment as usual (TAU) in patients with Major Depressive Disorder - the EMC trial (2010) (28)
- The non-steroidal anti-inflammatory drug tepoxalin inhibits interleukin-6 and alphal-anti-chymotrypsin synthesis in astrocytes by preventing degradation of IκB-alpha (1999) (28)
- Assessment of Microstressors in Adults: Questionnaire Development and Ecological Validation of the Mainz Inventory of Microstressors (2020) (28)
- 1‐trichloromethyl‐1,2,3,4‐tetrahydro‐β‐carboline‐induced apoptosis in the human neuroblastoma cell line SK‐N‐SH (2004) (27)
- Substance P induces expression of the corticotropin-releasing factor receptor 1 by activation of the neurokinin-1 receptor (2006) (27)
- Antibacterial activity of hyperforin from St John's wort (1999) (27)
- Lack of Breastfeeding: A Potential Risk Factor in the Multifactorial Genesis of Borderline Personality Disorder and Impaired Maternal Bonding. (2015) (27)
- BDNF Plasma Levels and BDNF Exon IV Promoter Methylation as Predictors for Antidepressant Treatment Response (2018) (26)
- Inhibition of substance P-induced cytokine synthesis by St. John's wort extracts. (2001) (26)
- Prenatal adversity: a risk factor in borderline personality disorder? (2012) (26)
- Right inferior frontal gyrus implements motor inhibitory control via beta-band oscillations in humans (2021) (26)
- Psychological interventions for people with narcissistic personality disorder (2014) (26)
- Medical students' attitudes to and contact with the pharmaceutical industry: a survey at eight German university hospitals. (2013) (26)
- Body mass index (BMI) in major depressive disorder and its effects on depressive symptomatology and antidepressant response. (2019) (25)
- Il-1β and Tnfα, but not Il-6, induce α1- antichymotrypsin expression in the human astrocytoma cell line U373 Mg (1995) (25)
- Preattentive information processing in schizophrenia (1994) (24)
- Longitudinal determination of resilience in humans to identify mechanisms of resilience to modern-life stressors: the longitudinal resilience assessment (LORA) study (2020) (24)
- Analysis of genome-wide significant bipolar disorder genes in borderline personality disorder (2014) (24)
- Neural Architecture of Selective Stopping Strategies: Distinct Brain Activity Patterns Are Associated with Attentional Capture But Not with Outright Stopping (2017) (23)
- Standardized Rater Training for the Hamilton Depression Rating Scale (HAMD17) and the Inventory of Depressive Symptoms (IDSC30) (2010) (23)
- Interleukin-1 beta and tumor necrosis factor-alpha induce expression of alpha 1-antichymotrypsin in human astrocytoma cells by activation of nuclear factor-kappa B. (1996) (23)
- The “DGPPN-Cohort”: a national collaboration initiative by the German Association for Psychiatry and Psychotherapy (DGPPN) for establishing a large-scale cohort of psychiatric patients (2013) (22)
- Association analysis of serotonin receptor 1B (HTR1B) and brain-derived neurotrophic factor gene polymorphisms in borderline personality disorder (2009) (22)
- The Serotonin Transporter Promoter Polymorphism (5-HTTLPR) Affects the Relation between Antidepressant Serum Concentrations and Effectiveness in Major Depression (2011) (22)
- Interessenkonflikte in der Medizin (2011) (22)
- Charakteristika von Studierenden, die pharmakologisches Neuroenhancement mit Stimulanzien betreiben: Eine Pilotstudie (2012) (21)
- Pharmacological neuroenhancement and the ability to recover from stress – a representative cross-sectional survey among the German population (2018) (21)
- Effects of substance P and its antagonist L-733060 on long term potentiation in guinea pig hippocampal slices (2005) (21)
- Interleukin-1 beta uses common and distinct signaling pathways for induction of the interleukin-6 and tumor necrosis factor alpha genes in the human astrocytoma cell line U373. (1996) (21)
- Potential link between interleukin-6 and arachidonic acid metabolism in Alzheimer's disease. (1998) (20)
- Valproic acid inhibits substance P‐induced activation of protein kinase C epsilon and expression of the substance P receptor (2003) (20)
- The Amount of Mitochondrial DNA in Blood Reflects the Course of a Depressive Episode (2016) (20)
- Borderline personality disorder (2021) (20)
- Individualized Web-Based Exercise for the Treatment of Depression: Randomized Controlled Trial (2018) (19)
- Depression, Borna disease, and amantadine (1997) (19)
- Substance P in serum and cerebrospinal fluid of depressed patients: No effect of antidepressant treatment (2005) (19)
- The use of Ginkgo biloba in healthy elderly (2014) (17)
- Attitudes towards prescribing cognitive enhancers among primary care physicians in Germany (2014) (17)
- The Frequent Stressor and Mental Health Monitoring-Paradigm: A Proposal for the Operationalization and Measurement of Resilience and the Identification of Resilience Processes in Longitudinal Observational Studies (2021) (16)
- Association analysis of SCN9A gene variants with borderline personality disorder. (2008) (16)
- Guideline adherence of antidepressant treatment in outpatients with major depressive disorder: a naturalistic study (2017) (16)
- Group Therapy Module to Enhance Self-Esteem in Patients with Borderline Personality Disorder: A Pilot Study (2010) (16)
- Pharmacological Neuroenhancement: Substances and Epidemiology (2013) (16)
- Applicability of a Web-Based, Individualized Exercise Intervention in Patients With Liver Disease, Cystic Fibrosis, Esophageal Cancer, and Psychiatric Disorders: Process Evaluation of 4 Ongoing Clinical Trials (2018) (15)
- Aktuelle Konzepte der Resilienzforschung (2018) (15)
- Teaching Conflicts of Interest and Shared Decision-Making to Improve Risk Communication: a Randomized Controlled Trial (2019) (15)
- Variable number of tandem repeat polymorphisms of the arginine vasopressin receptor 1A gene and impulsive aggression in patients with borderline personality disorder. (2012) (15)
- [Characteristics of university students using stimulants for cognitive enhancement: a pilot study]. (2012) (15)
- Data‐driven analysis of simultaneous EEG/fMRI reveals neurophysiological phenotypes of impulse control (2016) (15)
- Effects of substance P on memory and mood in healthy male subjects (2007) (15)
- Mental health and psychosocial support strategies in highly contagious emerging disease outbreaks of substantial public concern: A systematic scoping review. (2020) (14)
- Association analysis between gene variants of the tyrosine hydroxylase and the serotonin transporter in borderline personality disorder (2010) (14)
- [Improving general practitioners guided dementia care: the pilot project start-modem in Rheinland-Pfalz, Germany]. (2010) (14)
- Bornavirus and psychiatric disorders -- fact or fiction? (2001) (14)
- Impulsiveness and venturesomeness in German smokers. (2011) (13)
- Conflicts of Interest in Medicine. A Systematic Review of Published and Scientifically evaluated Curricula (2017) (12)
- Challenges in the Transition from In-Patient to Out-Patient Treatment in Depression. (2020) (12)
- Insomnia for 5 years (1999) (12)
- Potent inhibition of interleukin-6 expression in a human astrocytoma cell line by tenidap (1997) (12)
- Cannabis for Cognitive Enhancement as a New Coping Strategy? Results From a Survey of Students at Four Universities in Germany (2016) (12)
- Was ist Psychotherapie (2008) (12)
- Early improvement of executive test performance during antidepressant treatment predicts treatment outcome in patients with Major Depressive Disorder (2018) (12)
- Smoking and Neuropsychiatric Disease—Associations and Underlying Mechanisms (2021) (12)
- Das chronische Müdigkeitssyndrom („chronic fatigue syndrome“, CFS) Definition, diagnostische Maßnahmen und Therapiemöglichkeiten (1996) (11)
- Finanzierung von Arzneimittelstudien durch pharmazeutische Unternehmen und die Folgen (2010) (11)
- A generic solution for the operationalization and measurement of resilience and resilience processes in longitudinal observations: rationale and basic design of the MARP and LORA studies (2020) (11)
- Pharmacological interventions for people with borderline personality disorder. (2018) (11)
- Gruppentherapiemodul zur Stärkung des Selbstwertes bei Patientinnen mit Borderline-Persönlichkeitsstörung (2006) (11)
- Acute effect of intravenously applied alcohol in the human striatal and extrastriatal D2/D3 dopamine system (2017) (11)
- Aufwand und Finanzierung leitliniengerechter, psychotherapeutischer Behandlung im Krankenhaus (2015) (10)
- No modulatory effect of neurokinin-1 receptor antagonists on serotonin uptake in human and rat brain synaptosomes (2005) (10)
- Dopamine D2/D3 receptor availability and venturesomeness (2011) (10)
- Electroencephalographic coherence in acquired immune deficiency syndrome (1994) (10)
- Understanding and Predicting Antidepressant Response: Using Animal Models to Move Toward Precision Psychiatry (2018) (10)
- Voluntary disclosures of payments from pharmaceutical companies to healthcare professionals in Germany: a descriptive study of disclosures in 2015 and 2016 (2020) (10)
- Psychotherapie. Funktions- und störungsorientiertes Vorgehen (2016) (10)
- Verbesserte ambulante Demenzversorgung: Das hausarztbasierte rheinland-pfälzische Modellprojekt ¸¸start-modem (2010) (10)
- Pharmakologisches Neuroenhancement (2011) (10)
- Data-driven analysis of simultaneous EEG/fMRI using an ICA approach (2014) (10)
- [From symptomatic to disease modifying therapy? Recent developments in the pharmacotherapy of Alzheimer's disease]. (2009) (10)
- Discrepancies from registered protocols and spin occured frequently in randomized psychotherapy trials - a meta-epidemiologic study. (2020) (10)
- Dialektisch-behaviorale Therapie in der stationären Alkoholentwöhnung (2005) (10)
- Muster des Missbrauchs von (Psycho-) Stimulanzien zum pharmakologischen Neuroenhancement bei Studierenden (2011) (10)
- S08-01 - Cochrane Reviews of Pharmacological and Psychological Interventions for Antisocial Personality Disorder (ASPD) (2010) (10)
- Lack of modulating effects of the COMT Val(158)Met polymorphism on the association of serious life events (SLE) and impulsivity in patients with Borderline Personality Disorder. (2010) (10)
- [Interventions To Promote Resilience In Adults - A Narrative Review]. (2019) (9)
- [Current concepts of resilience research]. (2018) (9)
- Individual participant data systematic reviews with meta-analyses of psychotherapies for borderline personality disorder (2020) (9)
- Bouncing Back from the Burden of Dementia (2020) (9)
- Higher BDNF plasma levels are associated with a normalization of memory dysfunctions during an antidepressant treatment (2019) (9)
- Conflicts of interest in medical school: Missing Policies and high need for student information at most German Universities (2014) (8)
- Auswirkungen der COVID-19-Pandemie auf die Versorgungssituation in psychiatrischen Kliniken in Deutschland (2021) (8)
- Effects of age on depressive symptomatology and response to antidepressant treatment in patients with major depressive disorder aged 18 to 65 years. (2020) (8)
- Physical Activity in Polluted Air—Net Benefit or Harm to Cardiovascular Health? A Comprehensive Review (2021) (8)
- Psychological interventions for people with histrionic personality disorder (2012) (8)
- Psychotherapies for borderline personality disorder: a focused systematic review and meta-analysis (2022) (8)
- Cortical network mechanisms of response inhibition (2020) (7)
- Early onset of depression and treatment outcome in patients with major depressive disorder. (2021) (7)
- The non-steroidal anti-inflammatory drug tepoxalin inhibits interleukin-6 and alpha1-anti-chymotrypsin synthesis in astrocytes by preventing degradation of IkappaB-alpha. (1999) (7)
- Coping with COVID: risk and resilience factors for mental health in a German representative panel study (2022) (7)
- Sleep deprivation and growth-hormone secretion (2000) (7)
- Increased plasma concentration of maprotiline by coadministration of risperidone. (2002) (7)
- Psychological interventions for obsessive-compulsive personality disorder. (2010) (7)
- Trajectories of resilience and mental distress to global major disruptions (2022) (7)
- Zur aktuellen Situation der stationären Versorgung von Patienten mit Borderline-Persönlichkeitsstörung in Deutschland (2009) (6)
- Verkürzung der Übermittlungsdauer von Arztbriefen stationär behandelter Patienten in der Psychiatrie und Psychotherapie (2007) (6)
- Surprise: Unexpected Action Execution and Unexpected Inhibition Recruit the Same Fronto-Basal-Ganglia Network (2020) (6)
- Leitliniengerechte stationäre psychiatrisch-psychotherapeutische Behandlung der Borderline-Persönlichkeitsstörung (2016) (6)
- Schutzmechanismen gegen Burnout und Depression (2015) (6)
- Plain language summaries: A systematic review of theory, guidelines and empirical research (2021) (6)
- Evaluation of coercive measures in different psychiatric hospitals: the impact of institutional characteristics (2021) (6)
- Correction: Assessment of Microstressors in Adults: Questionnaire Development and Ecological Validation of the Mainz Inventory of Microstressors (2020) (6)
- A Group Intervention to Promote Resilience in Nursing Professionals: A Randomised Controlled Trial (2022) (5)
- Declaration and Handling of Conflicts of Interest in Guidelines: A Study of S1 Guidelines From German Specialist Societies From 2010-2013. (2015) (5)
- T36 Genome-Wide Association Study Of Borderline Personality Disorder Reveals Genetic Overlap With Bipolar Disorder And Schizophrenia (2017) (5)
- P-539 - A Meta-analysis of Executive Dysfunctions in Unipolar Major Depressive Disorder (mdd) Without Psychotic Symptoms and Their Changes During Antidepressant Treatment (2012) (5)
- Tolerability of High-Dose Venlafaxine After Switch From Escitalopram in Nonresponding Patients With Major Depressive Disorder (2020) (5)
- Longitudinal CSF proteome profiling in mice to uncover the acute and sustained mechanisms of action of rapid acting antidepressant (2R,6R)-hydroxynorketamine (HNK) (2021) (5)
- [Internet-based resilience training and prevention of mental disorders]. (2018) (5)
- Pharmacological and psychological interventions for antisocial personality disorder - Results of two cochrane reviews (2011) (5)
- Antipsychotika zur Behandlung neuropsychiatrischer Störungen bei Demenz (2013) (5)
- Mikroglia: Mechanismen der Aktivierung und Bedeutung bei der Pathogenese neuropsychiatrischer Erkrankungen (1998) (5)
- Absetzen von Antidepressiva – Absetzsymptome und Rebound-Effekte (2022) (5)
- The impact of physical fitness on resilience to modern life stress and the mediating role of general self-efficacy (2021) (5)
- [Impact of the COVID-19 pandemic on the care situation in psychiatric hospitals in Germany]. (2021) (5)
- KAPITEL 14 – Posttraumatische Belastungsstörungen (2009) (5)
- The Use of Pharmacologic Cognitive Enhancers in Competitive Chess. (2017) (5)
- The Independence of Research—A Review of Disciplinary Perspectives and Outline of Interdisciplinary Prospects (2021) (5)
- Effectiveness and cost-effectiveness for the treatment of depressive symptoms in refugees and asylum seekers: A multi-centred randomized controlled trial (2022) (5)
- [Patient attitudes and expectations towards conflicts of interest of attending physicians]. (2016) (4)
- Dialektisch-Behaviorale Therapie bei Patienten mit Alkoholabhängigkeit und komorbider Borderline-Persönlichkeitsstörung – erste Ergebnisse einer Pilotstudie (2008) (4)
- Pharmacotherapy of Borderline Personality Disorder: a Metaanalysis of Randomised Controlled Trials (2009) (4)
- Differentiation of hypothalamic GABAergic neurons in vitro: absence of effects of sex and gonadal steroids (2004) (4)
- Predictors of the effectiveness of an early medication change strategy in patients with major depressive disorder (2019) (4)
- Is pharmacotherapy useful for treating personality disorders? (2021) (4)
- Gesundheitsförderung und Resilienz (2018) (4)
- Substanz P-Rezeptor-Antagonisten als neues antidepressives und anxiolytisches Wirkprinzip? (2000) (4)
- Pharmacological interventions for paranoid personality disorder. (2011) (4)
- Transparency of Conflicts of Interest: A Mixed Blessing? The Patients' Perspective (2017) (4)
- Resilience beyond reductionism: ethical and social dimensions of an emerging concept in the neurosciences (2020) (4)
- Deep-brain stimulation for Parkinson's disease. (2006) (4)
- Immunologische Systemerkrankungen als Differentialdiagnose in der Psychiatrie (1997) (4)
- A combined marker of early non-improvement and the occurrence of melancholic features improve the treatment prediction in patients with Major Depressive Disorders. (2017) (4)
- Interventions to foster resilience in nursing staff: A systematic review and meta-analyses of pre-pandemic evidence. (2022) (3)
- Association between dopa decarboxylase gene variants and borderline personality disorder (2014) (3)
- Psychische Belastung, Resilienz und Absentismusneigung bei Gesundheitspersonal in Deutschland während der ersten COVID-19-Pandemiewelle im Frühjahr 2020 (2021) (3)
- Interessenkonflikte im Medizinstudium. Fehlende Regulierung und hoher Informationsbedarf bei Studierenden an den meisten deutschen Universitäten (2014) (3)
- Was wissen wir heute über die Borderline-Persönlichkeitsstörung? Aktuelles zu Ätiologie, Diagnostik und Therapie (2021) (3)
- Psychological interventions for avoidant personality disorder (2014) (3)
- Development of a checklist for evaluating psychiatric reports (2019) (3)
- Corrigendum to "Intervention studies to foster resilience - A systematic review and proposal for a resilience framework in future intervention studies" [Clinical Psychology Review 59 (2018) 78-100]. (2018) (3)
- Die neuen S3-Leitlinien: Borderline Persönlichkeitsstörung (2020) (3)
- Behandlungszufriedenheit von Patientinnen mit Borderline Persönlichkeitsstörung bei stationärer Schematherapie (2013) (3)
- Borderline personality disorder and the big five: molecular genetic analyses indicate shared genetic architecture with neuroticism and openness (2021) (3)
- [Stimulant and non-stimulant medication in current and future therapy for ADHD]. (2012) (3)
- Pharmakotherapie bei therapieresistenter Depression (2007) (3)
- The 5-HTTLPR polymorphism modulates the association of Serious Life Events and impulsivity in patients with Borderline Personality Disorder (2009) (3)
- [Chronic fatigue syndrome. Definition, diagnostic measures and therapeutic possibilities]. (1996) (3)
- Versorgungsalltag versus aktuelle externe Evidenz (2015) (3)
- [Guideline-adherent inpatient psychiatric psychotherapeutic treatment of borderline personality disorder : Normative definition of personnel requirements]. (2016) (3)
- A 48-year-old woman with panic attacks (2014) (3)
- Kapitel 17 – Borderline-Persönlichkeitsstörungen (ICD-10 F6) (2005) (3)
- Interventionen zur Resilienzförderung bei Erwachsenen (2019) (3)
- Development, implementation, and evaluation of a curriculum for medical students on conflicts of interest and communicating risk (2020) (3)
- Schematherapie mit dem Moduskonzept bei Persönlichkeitsstörungen (2009) (3)
- [Microglia: mechanisms of activation and significance in pathogenesis of neuropsychiatric illnesses]. (1998) (3)
- Association of Innate and Acquired Aerobic Capacity With Resilience in Healthy Adults: Protocol for a Randomized Controlled Trial of an 8-Week Web-Based Physical Exercise Intervention (2021) (2)
- The Catechol O-Methyltransferase (COMT) Val158Met polymorphism modulates the association of Serious Life Events (SLE) and impulsive aggression in female patients with Borderline Personality Disorder (2009) (2)
- Die ärztliche Unabhängigkeit steht auf dem Spiel (2013) (2)
- [Borna disease virus and psychiatric diseases. Fact or artefact?]. (2009) (2)
- Wem gehört die Psychotherapie (2006) (2)
- [Accelerating consult letter time in inpatient psychiatric and psychotherapeutic care]. (2007) (2)
- Schutzschild gegen Stress (2016) (2)
- Impact of physicians’ participation in non-interventional post-marketing studies on their prescription habits: A retrospective 2-armed cohort study in Germany (2020) (2)
- Was tun Sie, wenn der Patient tobt? (2003) (2)
- Abhängigkeitserkrankungen (2019) (2)
- [Pharmacological therapy for therapy-resistant depression. New developments]. (2007) (2)
- Changes and Challenges in Inpatient Mental Health Care During the First Two High Incidence Phases of the COVID-19 Pandemic in Germany – Results From the COVID Ψ Psychiatry Survey (2022) (2)
- Pharmacological interventions for schizotypal personality disorder. (2011) (2)
- [Current status of inpatient treatment for borderline personality disorders in Germany]. (2009) (2)
- Sind Anwendungsbeobachtungen ein Marketing-Tool? (2018) (2)
- IS ALREADY THE PREATTENTIVE VISION DISTURBED IN SCHIZOPHRENICS? (1992) (2)
- Zauberformel für die Seele (2017) (2)
- 189 Preclinical activity of the poly (ADP-ribose) polymerase (PARP) inhibitor ABT-888 in combination with irinotecan in ovarian and triple negative breast cancers (2010) (2)
- Pharmacological interventions for people with narcissistic personality disorder (2011) (2)
- Psychological interventions for avoidant personality disorder (Protocol) (2012) (2)
- [Acute treatment of psychiatric excitation. What to do when the patient is out of control?]. (2003) (2)
- Strategies to delay the onset of Alzheimer's disease. (2000) (2)
- Internetbasierte Resilienzförderung und Prävention psychischer Erkrankungen (2018) (2)
- [Substance P-antagonists as a new class of antidepressant drugs]. (2002) (2)
- Die S3-Leitlinie Borderline-Persönlichkeitsstörungen (2022) (2)
- A distinct transcriptional signature of antidepressant response in hippocampal dentate gyrus granule cells (2021) (2)
- Offenlegung von Interessenkonflikten (2011) (2)
- IL-1 beta and TNF alpha, but not IL-6, induce alpha 1-antichymotrypsin expression in the human astrocytoma cell line U373 MG. (1995) (2)
- Systematic review and meta-analysis on the therapeutic reference range for escitalopram: Blood concentrations, clinical effects and serotonin transporter occupancy (2022) (1)
- Schematherapie — ein Verfahren der „3. Welle“ kognitiver Verhaltenstherapie (2017) (1)
- Antagonisten am Substanz-P-Rezeptor als neue Klasse von Antidepressiva (2002) (1)
- Korruption im Gesundheitswesen (2017) (1)
- Modulation von Peptidrezeptoren (2005) (1)
- Was nicht veröffentlicht wird (2014) (1)
- Bestandteile der Materie: Atome, Moleküle, Atomkerne, Elementarteilchen (2003) (1)
- Quetiapin zur Behandlung der Borderline-Persönlichkeitsstörung? (2014) (1)
- Psychopharmakologische Akutbehandlung der unipolaren Depression (2009) (1)
- Störungsspezifische Pharmakotherapie: Borderline-Persönlichkeitsstörung (2011) (1)
- Antidepressiva bei Patienten mit Borderline-Persönlichkeitsstörung (2012) (1)
- Interessenkonflikte durch Arzt-Industrie-Kontakte in Praxis und Klinik und Vorschläge zu deren Reduzierung (2011) (1)
- Einstellungen und Erwartungen von Patienten in Bezug auf Interessenkonflikte ihrer behandelnden Ärzte (2016) (1)
- Auswirkungen von Interessenkonflikten auf Arzneimittelstudien (2011) (1)
- Transparenz allein reicht bei Interessenkonflikten nicht aus – Pro (2015) (1)
- Kapitel 43 – Psychotherapieforschung (2017) (1)
- Interessenkonflikte in der Medizin durch Arzt-Industrie-Beziehungen (2011) (1)
- Psychiatrische Diagnostik (2019) (1)
- Kapitel 24 – Borderline-Persönlichkeitsstörungen (2017) (1)
- Resilienz – Die Widerstandskraft stärken (2018) (1)
- Auch zu Weihnachten keine Geschenke! (2017) (1)
- Methoden der Kosten-Nutzen-Bewertung im Gesundheitswesen (2009) (1)
- Selbstverletzung: ein früher Indikator für Probleme (2015) (1)
- Nocturnal Serum Leptin Values in Chronic Primary Insomnia: A Preliminary Report. Nchtliche Leptin-Ausschttung bei Primrer Insomnie: eine Pilotstudie (2006) (1)
- Altered DNA methylation status (BDNF gene exon IV) associated with prenatal maternal cigarette smoking in borderline patients and healthy controls (2015) (1)
- FC14-03 - First results of the compas group (comparison of methylphenidate and psychotherapy in adult ADHD study) (2011) (1)
- Perspectives of psychotherapy (2008) (1)
- Mainz Inventory of Microstressors (MIMIS): Development and ecological validation of a microstressor scale for adults (Preprint) (2019) (1)
- [Resource use and financing of guideline-adherent psychotherapeutic inpatient care]. (2015) (1)
- [Treatment satisfaction of patients with borderline personality disorder in inpatient schema therapy]. (2013) (1)
- P.1.a.026 Methylation of the promoter of brain-derived neurotrophic factor exon IV and antidepressant response in major depression (2014) (1)
- Pharmakologische Behandlung von Borderline-Persönlichkeitsstörungen (2014) (1)
- The Brain-Derived Neurotrophic Factor (BDNF) Val66Met polymorphism modulates the effects of serious life events on impulsive aggression in patients with Borderline Personality Disorder (2009) (1)
- Physicians’ attitudes towards disclosure of payments from pharmaceutical companies in a nationwide voluntary transparency database: a cross-sectional survey (2022) (1)
- Brief Resilience Scale--German Version (2018) (1)
- Mental Health Impact of Early Stages of the COVID-19 Pandemic on Individuals with Pre-Existing Mental Disorders: A Systematic Review of Longitudinal Research (2023) (1)
- [Application of dialectical behavior therapy as in-patient treatment for alcohol dependency]. (2005) (1)
- [Stopping antidepressants: withdrawal symptoms and rebound effects : Review and practical recommendations]. (2022) (1)
- Routinely accessible parameters of mineralocorticoid receptor function, depression subtypes and response prediction: a post-hoc analysis from the early medication change trial in major depressive disorder (2022) (1)
- Influence of gender on cytokine induced depression and treatment: Gender aspects of IFN-α-induced depression. (2021) (1)
- [Antipsychotics for treatment of neuropsychiatric disorders in dementia]. (2013) (1)
- Pharmacological Neuroenhancement, Perceived Stress and Resilience in Spine Surgeons - a Cross-Sectional Survey. (2021) (1)
- The association of innate and acquired aerobic capacity with resilience in healthy adults: Protocol for an eight-week randomized controlled web-based physical exercise intervention study (Preprint) (2021) (1)
- P02-261 - Efficacy of Psychotherapies for Borderline Personality Disorder - a Meta-Analysis of Randomized Controlled Trials (2010) (1)
- Perceived threat modulates inhibitory performance. (2020) (1)
- Pharmacological interventions for obsessive-compulsive personality disorder. (2010) (1)
- Pharmacological interventions for schizoid personality disorder (2014) (1)
- IL-1b uses common and distinct signalling pathways for induction of the IL-6 and TNF-a genes in the astrocytoma cell line U373. (1996) (1)
- P.0803 Association of polygenic risk scores and hair cortisol with mental health trajectories during COVID-lockdown (2021) (1)
- Nocturnal serum leptin values in chronic primary insomnia: A preliminary report (2006) (1)
- Functional downregulation of the neurokinin 1 receptor by antidepressant, neuroleptics and mood stabilizers (2005) (1)
- Life context of pharmacological academic performance enhancement among university students – a qualitative approach (2014) (1)
- [Systemic immunologic diseases as differential diagnosis in psychiatry]. (1997) (1)
- The Importance of Assessing Mental Health Issues and Preventing Suicidality in Studies on Healthy Participants (2020) (1)
- Pharmacotherapy in patients with cluster a personality disorders (2011) (1)
- A coordinate-based ALE functional MRI meta-analysis of brain activation during verbal fluency tasks in healthy control subjects (2014) (1)
- AS14-02 - Common and Distinct Treatment Elements in Psychotherapies for Borderline Personality Disorder (2012) (1)
- [What do we know about borderline personality disorder? Current aspects of etiology, diagnostics and treatment]. (2021) (1)
- AS14-01 - Comparative Efficacy of Evidence Based Psychotherapies in the Treatment of Borderline Personality Disorder (2012) (1)
- COVID-19 vaccination rates in hospitalized mentally ill patients compared to the general population in Germany: Results from the COVID Ψ Vac study (2022) (1)
- Resilience Interventions Conducted in Western and Eastern Countries—A Systematic Review (2022) (1)
- Emotional Modulation of Impulse-control in Borderline Personality Disorder (2009) (0)
- Affektive Störungen (2019) (0)
- The use of Ginkgo biloba in healthy elderly (2013) (0)
- The effects of long-term psychotherapeutic treatments for borderline personality disorder (2017) (0)
- The resilience framework as a strategy to combat stress-2 related disorders 3 4 5 (2017) (0)
- Escitalopram for the prevention of peginterferon alpha-2a- and ribavirin-associated depression in HCV-infected patients without prior psychiatric disease: A randomized controlled trial (2012) (0)
- Corrigendum to ‘State dependent posterior hippocampal volume increases in patients with major depressive disorder’ [J. Affect. Disord. 135 (1–3) (2011) 405–409] (2016) (0)
- Acculturation and Anger Expression Among Iranian Migrants in Germany (2022) (0)
- Differentially methylated regions in antidepressant response- a methylome-wide association study from the EMC trial (2022) (0)
- Effects of general and corona-specific stressors on mental burden during the SARS-CoV-2 pandemic in Germany (2022) (0)
- [Dementias--diagnosis, differential diagnosis and therapy]. (1996) (0)
- Pharmacotherapy of Borderline Personality Disorder: A Metaanalysis of Randomised Controlled Trials (2009) (0)
- The Influence of Therapeutic Drug Monitoring (TDM) and Objective Symptom Rating for Prediction of Antipsychotic Response to Second-Generation Antipsychotic Drugs (2008) (0)
- Authors' response to "Comment on Kunzler et al. (2022) 'Interventions to foster resilience in nursing staff: A systematic review and meta-analyses of pre-pandemic evidence'". (2022) (0)
- Ascorbic acid inhibits prostaglandin E2 release in primary rat microglia (2002) (0)
- Interventions to Promote Resilience in Adults (2020) (0)
- Publication-Bias bei Psychotherapiestudien (2015) (0)
- Vorwort zur 9. Auflage (2019) (0)
- [Diagnosis of Obsessive Compulsive Disorder in Refugees: Are We Asking The Right Questions?] (2020) (0)
- P01-92 - Early Changes are Associated with late Changes of BDNF Serum Levels in Inpatients with Major Depression During Short-term Antidepressant Treatment (2010) (0)
- 298 ESCITALOPRAM FOR THE PREVENTION OF PEG-IFN-α AND RIBAVIRIN ASSOCIATED DEPRESSION IN HCV-INFECTED PATIENTS: FINAL RESULTS FROM THE CIPPAD-TRIAL (2010) (0)
- Modulation of neuropeptidergic circuits (2004) (0)
- Maternal stress during pregnancy predicts methylation of the glucocorticoid receptor gene (NR3C1) in borderline personality disorder (2019) (0)
- P.0884 Routinely accessible parameters of mineralocorticoid receptor function, depression subtypes and response prediction: a post-hoc analysis from an antidepressant treatment trial (2021) (0)
- Valproic acids inhibits interleukin-1-induced expression of cyclooxigenase-2 and prostaglandin release in human neuroblastoma cells (2004) (0)
- Serum and cerebrospinal fluid concentration of Substance P before and after treatment of depressed patients (2004) (0)
- Effectiveness of Antipsychotic Medication in the Treatment of BPD (2017) (0)
- [Unresponsive patient. What should be done in stupor?]. (2003) (0)
- Development of a checklist for evaluating psychiatric reports (2019) (0)
- Interference of psychopharmacological agents with substance P-induced gene expression and expression of the receptor for substance P (2004) (0)
- Spin and Outcome Reporting Bias in Randomized Controlled Trials of Psychological Interventions on Depression (2018) (0)
- [Antidepressants should be carefully prescribed in patients with mild forms of depression]. (2011) (0)
- New Efforts towards Evidence-Informed Practice and Practice-Informed Research: Commentary on Recent Developments in the Pharmacologic Management of Personality Disorders (2020) (0)
- [The national treatment guidelines on depression need more courageous and more differentiated statements on psychotherapy]. (2022) (0)
- W05-01 - Rationale and Design of an RCT Comparing “EMC-Strategy” with TAU in Patients with Major Depression - the EMC Trial (2010) (0)
- Are Treatment Gains Maintained? Long-term Psychological Interventions for Bordeline Personality Disorder (2017) (0)
- Anti-inflammatory therapeutic strategies in Alzheimer's disease (1998) (0)
- [COVID-19 vaccination for people with severe mental diseases : Results of the COVID Ψ outpatient survey and recommendations for psychiatry]. (2023) (0)
- W45. METHYLOME-WIDE ASSOCIATION STUDY OF ANTIDEPRESSANT TREATMENT RESPONSE (2021) (0)
- Substance P and substance P antagonists in the pathology and treatment of affective disorders (2004) (0)
- The Role of Cytokines in Alzheimer’s Disease (1997) (0)
- 42. The mood stabilizer valproic acid down regulates neuronal cyclooxygenase-2 expression: Central role of nuclear factor-kappa B after long-term, but not short-term treatment (2009) (0)
- Dissociable attentional and inhibitory networks of dorsal and ventral areas of the right inferior frontal cortex: a combined task-specific and coordinate-based meta-analytic fMRI study (2015) (0)
- Rapid acting antidepressant (2R,6R)-hydroxynorketamine (HNK) targets glucocorticoid receptor signaling: a longitudinal cerebrospinal fluid proteome study (2020) (0)
- Neue und überraschende Daten (2015) (0)
- Was ist eine "gute" Plain Language Summary? Ein systematisches Review über laienverständliche Kommunikation wissenschaftlicher Evidenz (2021) (0)
- Clinical trials in personality disorders: Recommendations for study design and conduct. (2023) (0)
- [There is no Season for Gifts]. (2017) (0)
- Die Corona-Pandemie und neue online-Formate der Aus-, Weiter- und Fortbildung (2021) (0)
- Psychiatrische Notfälle (2019) (0)
- Perspectives on Dialectical Behavior Therapy and Mentalization-Based Therapy for Borderline Personality Disorder: Same, Different, Complementary? (2022) (0)
- Technisch durchführbar und verträglich (2015) (0)
- Die Eignung zementgebundener Span-und Faserplatten zum Einsatz als Doppelboden (2007) (0)
- "Es war ungeheuer lohnend, Physik zu studieren" - Carl Friedrich von Weizäcker als Physiker (2009) (0)
- Hohe Opiatdosis reduziert spinale Langzeitpotenzierung: Wird die Schmerztherapie revolutioniert? (2012) (0)
- Dr. Web? — „Gesundheitsinformation.de“ sollten alle Patienten kennen (2017) (0)
- Organische psychische Störungen/neurokognitive Störungen (2019) (0)
- Therapie psychischer Erkrankungen (2019) (0)
- Zur pathophysiologischen Bedeutung der Amygdala in der Affektregulation bei psychischen Störungen (2005) (0)
- [Management of acute suicidality]. (2004) (0)
- AkdÄ schafft Transparenz (2014) (0)
- Verhaltenstherapie reduziert Tic-Symptome (2013) (0)
- Regloser patient: Was tun bei stuporösen Zuständen? (2003) (0)
- Rechtsgrundlage für Zwangsbehandlungen muss schnell geschaffen werden (2012) (0)
- Perspektiven der Psychotherapie (2008) (0)
- B κ in IL-6 Expression Independently from NF-Mitogen-Activated Protein Kinase Resulting The Neuropeptide Substance P Activates p 38 (2000) (0)
- Brauchen wir einen Physician Payments Sunshine Act in Deutschland? (2014) (0)
- Interventionen zur Steigerung der Resilienz (2021) (0)
- Schematherapie bei Persönlichkeitsstörungen (2014) (0)
- Berufsgruppenspezifische Prävalenz von pharmakologischem Neuroenhancement (2019) (0)
- Notfälle bei Persönlichkeitsstörungen: Pharmakotherapie (2013) (0)
- Zauberformel für die Seele (2016) (0)
- [Mental burden, resilience and tendency towards absenteeism among healthcare personnel in Germany during the first wave of the COVID-19 pandemic in spring 2020 : An ad hoc survey]. (2021) (0)
- Die meisten Patienten vertrauen ihren Ärzten (2014) (0)
- Antisuizidaler Effekt von Lithium in großer schwedischer Registerstudie bestätigt (2018) (0)
- Neurobehaviorale Grundlagen der Impulskontrolle und Impulsivität und deren Bedeutung für Suchterkrankungen (2011) (0)
- Childhood sexual abuse predicts methylation of the glucocorticoid receptor gene (NR3C1) in borderline personality disorder patients and controls (2017) (0)
- Longitudinal cerebrospinal fluid proteome profiling of acute and sustained antidepressant-like effects of (2R,6R)-hydroxynorketamine (HNK) reveals involvement of glucocorticoid receptor signaling (2020) (0)
- Umstellen oder Augmentieren bei Nichtansprechen auf Antidepressiva? (2017) (0)
- Research Domain Criteria — in Deutschland noch zu wenig bekannt (2015) (0)
- Extinction of cognitively conditioned fear in Borderline Personality Disorder (2008) (0)
- Pharmakologisches Neuroenhancement: Substanzen und Epidemiologie (2012) (0)
- Bundesverfassungsgericht zu Fixierungen (2018) (0)
- Identification of disulfiram as a secretase-modulating compound with beneficial effects on Alzheimer’s disease hallmarks (2018) (0)
- Adressen (2017) (0)
- Auch per Telefon wirksam (2012) (0)
- Kapitel 42 – Interessenkonflikte in der Psychotherapie (2017) (0)
- Unbehandelte Psychose verschlechtert die Prognose (2014) (0)
- Ein Überblick über störungsspezifische Psychotherapieansätze (2017) (0)
- Epigenetic signatures in antidepressant treatment response: a methylome-wide association study in the EMC trial (2022) (0)
- Ein schöner Wunschzettel zu Weihnachten (2013) (0)
- Nikotinabhängige Raucher: Zusammenhang von Raucherstatus, Geschlecht und ADHS (2009) (0)
- Zauberformel für die Seele (2017) (0)
- Einfluss anzunehmen, aber nicht bewiesen (2013) (0)
- Emotionale Modulation der Impulskontrolle bei der Borderline-Persönlichkeitsstörung (2009) (0)
- Schizophrenien und andere psychotische Störungen (2019) (0)
- Was ist eine psychische Störung (2008) (0)
- Das Mündliche EXamen - Psychiatrie (2018) (0)
- Human impulsivity is modulated by extrastriatal dopaminergic neurotransmission (2010) (0)
- Hirn-Doping wird beliebter (2015) (0)
- Einführung (2019) (0)
- Kultursensitives Behandlungskonzept für Menschen mit Migrationshintergrund und Geflüchtete (2019) (0)
- Sterblichkeit im Vergleich zur Normalbevölkerung bleibt weiter erhöht (2018) (0)
- Antipsychotikum zur Augmentierung? (2016) (0)
- Die Corona-Krise als Chance? (2020) (0)
- Die Verschreibungspraxis von Psychopharmaka ändert sich (2013) (0)
- Postakute Behandlung alkoholabhängiger Patienten: Therapiebausteine einer Suchtambulanz (2009) (0)
- 20 Jahre „INFO Neurologie & Psychiatrie“ (2018) (0)
- Koalition gegen psychische Erkrankungen (2018) (0)
- Medizinische Ausbildung und Pharmamarketing (2018) (0)
- DEMENZERKRANKUNGEN : DIAGNOSE, DIFFERENTIALDIAGNOSE UND THERAPIE (1996) (0)
- Impfbereitschaft von Krankenhauspersonal in Deutschland: Welche Rolle spielen Verschwörungsannahmen zu COVID-19? (2022) (0)
- Personal in der Corona-Krise - zwischen Belastung und Resilienz (2021) (0)
- Autorinnen und Autoren (2019) (0)
- Diagnosestellung von Zwangsstörungen bei geflüchteten Patienten. Stellen wir die richtigen Fragen? (2020) (0)
- Zu Risiken- und Nebenwirkungen… (2017) (0)
- Weiterfinanzierung dringend gesucht (2016) (0)
- Die Initiative „Choosing wisely“ sollte auch hierzulande mehr Gehör finden (2015) (0)
- Polypharmazie ist Usus — obwohl es dafür keinerlei Empfehlungen gibt (2015) (0)
- Psychiatrische Begutachtung und andere rechtliche Aspekte (2019) (0)
- The effects of short-term psychotherapeutic treatments for borderline personality disorder - findings from a Cochrane review (2017) (0)
- Störungsorientierte, evidenz- basierte Psychotherapiever- fahren am Beispiel der Border- line-Persönlichkeitsstörung Was können wir daraus für die Weiterentwicklung der Psychotherapie lernen und fordern? (2012) (0)
- Neue Daten aus einer Cochrane-Analyse (2012) (0)
- [Transparency alone is not sufficient for the management of conflicts of interest - pro]. (2015) (0)
- Abstracts Second Congress of the European Society for Clinical Neuropharmacology (1995) (0)
- Auswirkungen von postnatalem Stress auf die Entwicklung des Gehirns: Bildgebung und Volumetrie des Hippocampus mittels in vivo MRT in Mäusen (2008) (0)
- Das Projekt PLan Psy: Evidenzbasierte Kommunikation psychologischer Forschung mittels Plain Language Summaries (2021) (0)
- Widerstandskraft im Alter: Mit Resilienz gesund alt werden (2019) (0)
- Wirkung von Citalopram und Paroxetin nicht durch Nebenwirkungen erklärbar (2018) (0)
- 49-9 Analysis of the transcriptional regulation of cytokine gene expression in the brain as rationale for the search for antiinflammatory drugs (1997) (0)
- Fronto-striatale Netzwerkstörung im Gehirn als Risikofaktor? (2012) (0)
- Schizophrenie — eine Angststörung? Aktuelle Hinweise für eine neue Sichtweise (2017) (0)
- Von der symptomatischen zur kausalen Therapie? Neue Entwicklungen in der Pharmakotherapie der Alzheimer-Demenz (2009) (0)
- Early deprivation and brain development in mice as a model system for trauma-related psychiatric disorders (2005) (0)
- Clonidine in the treatment of acute states of aversive tension and dissociation in female patients with borderline personality disorder (2004) (0)
- Borderline-Persönlichkeitsstörungen (ICD-10 F6) (2019) (0)
- Lithium und Depot-Antipsychotika verhindern Rückfälle am besten (2018) (0)
- Umdenken ist angesagt (2012) (0)
- Mehr Unabhängigkeit ist notwendig und möglich (2016) (0)
- Altbekanntes und einige Überraschungen (2012) (0)
- Die NVL Depression benötigt mutigere und differenziertere Aussagen zur Psychotherapie (2022) (0)
- Evidenzbasierte Medizin: Von der nachrangigen Bedeutung des p-Wertes (2017) (0)
- Elektrophysiologische Phänotypen der motorischen Impulskontrolle (2013) (0)
- Störungsspezifische Psychotherapie der Borderline-Persönlichkeitsstörung (2020) (0)
- Resilienz – Paradigmenwechsel in der klinischen Forschung (2014) (0)
- InFo Neurologie & Psychiatrie punktet bei den Lesern (2016) (0)
- Verschreibungspraxis bei Antipsychotika (2015) (0)
- Was macht uns widerstandsfähig gegen Stress? (2015) (0)
- Resilienz – Die Widerstandskraft stärken (2018) (0)
- Bundesverfassungsgericht entscheidet zu Fixierungen (2018) (0)
- Erst nach zehn Jahren Abstinenz wieder auf Nichtraucherniveau (2012) (0)
- Author response: Right inferior frontal gyrus implements motor inhibitory control via beta-band oscillations in humans (2021) (0)
- ICD-11 seit 1.1.2022 online (2022) (0)
- Solanezumab auch bei milder Alzheimer-Demenz wirkungslos (2018) (0)
- Schutzschild gegen Stress (2016) (0)
- Differential associations of leisure music engagement with resilience: A network analysis (2023) (0)
- Störungsorientierte, evidenzbasierte Psychotherapieverfahren am Beispiel der Borderline-Persönlichkeitsstörung (2012) (0)
- PW01-31 - Early Increase of Peripheral BDNF In Major Depression During Antidepressant Treatment Predicts Late BDNF Increase With High Sensitivity and Specificity (2010) (0)
- „Die passende Chemie wäre entscheidend … wenn man denn eine Wahl hätte“ – eine qualitative Studie zu Präferenzen von Therapiesuchenden einer ambulanten Psychotherapie (2023) (0)
- Zum Teil sehr große Unterschiede (2014) (0)
- Industrie-Einflüsse auf die Arzneimittelversorgung – mehr Unabhängigkeit ist möglich (2017) (0)
- Resilienzforschung und Prävention (2021) (0)
- Evidence for a shared genetic contribution to loneliness and Borderline Personality Disorder (2023) (0)
- Die Eignung zementgebundener Span-und Faserplatten zum Einsatz als Doppelboden (1990) (0)
- Antidepressive Effekte von Vortioxetin in einer Metaanalyse von elf Studien bestätigt (2016) (0)
- COVID-19-Impfung für Menschen mit schweren psychischen Erkrankungen (2023) (0)
- Verhaltenstherapie zur Steigerung des Selbstwertes bei Patienten mit Persönlichkeitsstörungen (2007) (0)
- Facetten der Impulsivität bei Alkoholabhängigen (2011) (0)
- Development and evaluation of a smartphone-based positivity training – Study conc (2017) (0)
- Schematherapie quo vadis (2011) (0)
- Gedächtnisverbesserung durch tiefe Hirnstimulation? (2012) (0)
- Was nicht veröffentlicht wird (2014) (0)
- Psychotherapy and pharmacotherapy research in contrast: similarities, differences and outlook (2017) (0)
- Sind Anwendungsbeobachtungen ein Marketing-Tool? (2018) (0)
- Clozapin und Depotpräparate schützen bei Schizophrenie am besten vor Rückfällen (2018) (0)
- Nicht nur bei dissoziativen Störungen und PTBS verbreitet (2018) (0)
- Wird die Schmerztherapie revolutioniert? (2012) (0)
- Das Mainzer Ausbildungsbuch (2010) (0)
- [Also Z drugs are abused]. (2015) (0)
- Erhöhte Suizidrate nach Erhalt der Krebsdiagnose (2012) (0)
- Empfehlung zur pharmakologischen Behandlung von Borderline-Persönlichkeitsstörungen (2014) (0)
- Mehr Personal für unsere Patienten! (2019) (0)
- Mehr Transparenz Wie sollte Wissenschaft ihre Beziehung zur Pharmaindustrie gestalten? (2020) (0)
- “The right chemistry would be decisive … if only one had a choice”—A qualitative analysis of clients’ preferences when searching for outpatient psychotherapy (2023) (0)
- Korruption im Gesundheitswesen (2017) (0)
- [What will not be publicized]. (2014) (0)
- Systematic review of psychotherapeutic treatments for “minor” personality disorders (2011) (0)
- Short-term Psychological Interventions for Bordeline Personality Disorder–What Works? (2017) (0)
- Wie belastend ist der Erhalt einer Krebsdiagnose? (2012) (0)
- Escitalopram zur Prävention von peg-IFN-α und Ribavirin assoziierten Depressionen bei HCV-infizierten Patienten: Abschließende Ergebnisse der CIPPAD-Studie (2010) (0)
- Lithium ist Quetiapin überlegen (2017) (0)
- Kombination von Antidepressiva (2009) (0)
- Mehr Personal für eine moderne Versorgung psychischer Störungen (2020) (0)
- Persönlichkeitsstörungen (2019) (0)
- Nachwuchsrekrutierung für die Psychiatrie und Psychotherapie (2016) (0)
- Warum Ärzte trotz BGH-Beschluss keine Geschenke annehmen sollten (2012) (0)
- Haben Zolpidem und Zopiclon antidepressive Effekte? (2017) (0)
- Pharmacological interventions for people with histrionic personality disorder (2011) (0)
- Auch Z-Substanzen werden missbraucht (2015) (0)
- Die Erwartungen wurden nicht erfüllt (2013) (0)
- Wirken Z-Substanzen auch antidepressiv? (2017) (0)
- S.13.01 Prediction of treatment outcome in major depressive disorder by clinical and biological markers: new developments towards an individualised treatment and prognosis (2014) (0)
- The German BPD guidelines in progress (2018) (0)
- The resilience framework as a strategy to combat stress-related disorders (2017) (0)
- QTc interval alterations during antidepressant treatment with escitalopram and venlafaxine (2022) (0)
- Resilience beyond reductionism: ethical and social dimensions of an emerging concept in the neurosciences (2020) (0)
- Antipsychotics and Borderline Personality Disorder Sample Bias May Obscure Results (0)
- The development of body mass index (BMI) in depressed patients during an antidepressant treatment and its effects on depressive symptomatology (2020) (0)
- Systematic review of psychotherapeutic treatments for “minor” personality disorders (2011) (0)
- [Self injury behavior: an early indication of problems]. (2015) (0)
- [Brain doping becomes more popular]. (2015) (0)
- Disturbed fronto-limbic brain circuits in borderline personality disorder (2005) (0)
- [Substance P receptor antagonists--a new antidepressive and anxiolytic mechanism?]. (2000) (0)
- WITHDRAWN: Association analysis between the early change of serum brain-derived neurotrophic factor (sBDNF) and final change of depression severity during antidepressant treatment: A pilot study. (2010) (0)
- Noise annoyance and risk of prevalent and incident atrial fibrillation–A sex-specific analysis (2022) (0)
- Prägend wie kein anderer — zur Emeritierung unseres Mitherausgebers (2016) (0)
- [University privatization as a prospect or nightmare]. (2006) (0)
- 65-130 Deficits in parallel cortical processing of visual information in schizophrenic patients (1997) (0)
- SOCIReM: Second Order effects of Conflict of Interest Regulations in Medicine (2018) (0)
- P.0819 Usefulness of haircortisol as a biological correlate for resilience to everyday life stress (2021) (0)
- Nonsteroidal drugs and Alzheimer's disease. (2002) (0)
- Interleukine-6 and high-sensitive CRP plasma levels and antidepressant response- A secondary analysis from the Early Medication Change (EMC) trial (2022) (0)
- How Prevalent is Conflict of Interest in the Medical Profession (2017) (0)
- Do Mood Stabilizers Help in Borderline Personality Disorder? (2017) (0)
- Authors' reply (2010) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Klaus Lieb?
Klaus Lieb is affiliated with the following schools:
